CBO Says Senate User Fee Package Will Decrease Direct Spending
This article was originally published in The Pink Sheet Daily
Executive Summary
While drug development incentives will increase federal health care program spending, other provisions designed to allow lower-cost drugs on the market faster are expected to reduce costs.